TABLE 2.
Univariable Comparisons Considering Only Patients Suffering Nonconvulsive Status Epilepticus (Upper Part) and Patients With Status Epilepticus Detected Greater Than 24 Hours After ICU Admission (Lower Part)
| NCSE | Without ICU-Electroencephalogram Unit (29) | With ICU-Electroencephalogram Unit (23) | p |
|---|---|---|---|
| Demographics data | |||
| SE patients/yr, mean ± sd | 4.7 (± 1.1) | 8.5 (± 0.7) | 0.08 |
| Male: female ratio | 14: 15 | 14: 9 | 0.5 |
| Age, mean ± sd | 63.0 (± 17.8) | 59.0 (± 16.8) | 0.6 |
| SE features | |||
| SE duration, d, mean ± sd | 3.7 (± 4.6) | 1.3 (± 1.2) | 0.017 |
| NCSE type: | |||
| Focal NCSE without coma, n (%) | 13 (45) | 10 (55) | 0.9 |
| With altered consciousness | 11 | 8 | |
| Without altered consciousness | 2 | 2 | |
| NCSE with coma, n (%) | 16 (55) | 13 (57) | 0.9 |
| SE etiology, n (%): | |||
| Acute symptomatic | 14 (48) | 17 (74) | 0.06 |
| Remote symptomatic | 8 (28) | 1 (4) | 0.028 |
| Progressive symptomatic | 5 (17) | 4 (17) | 0.9 |
| Unknown | 2 (7) | 1 (4) | 0.7 |
| Potentially fatal etiology, n (%) | 13 (45) | 10 (44) | 0.9 |
| Management data | |||
| ICU stay, d, mean ± sd | 14 (± 15.6) | 12 (± 7.7) | 0.6 |
| Number of ASMs, mean ± sd | 2.7 (± 1.6) | 2.9 (± 1.4) | 0.3 |
| SE patients intubated during SE, n (%) | 26 (90) | 19 (83) | 0.5 |
| SE patients with IV anesthetics during SE, n (%) | 24 (83) | 14 (61) | 0.08 |
| Outcome, n (%) | |||
| Death | 5 (17) | 5 (22) | 0.7 |
| Return to premorbid neurologic function | 6 (21) | 11 (47) | 0.038 |
| SE Detected > 24 hr After ICU Admission | Without ICU-Electroencephalogram Unit (14) | With ICU-Electroencephalogram Unit (13) | p |
|---|---|---|---|
| Demographics data | |||
| SE patients/yr, mean ± sd | 2.3 (± 1.37) | 5.5 (± 0.71) | 0.07 |
| Male: female ratio | 6:8 | 8:5 | 0.3 |
| Age, mean ± sd | 58.5 (± 18.5) | 58.5 (± 19.8) | 0.9 |
| SE features | |||
| SE duration, d, mean ± sd | 4.8 (± 5.4) | 1.0 (± 0.5) | 0.003 |
| SE type, n (%) | 0.9 | ||
| SE with prominent motor symptoms patients | 12 (86) | 11 (85) | |
| NCSE | 2 (14) | 2 (15) | |
| SE etiology, n (%): | |||
| Acute symptomatic | 11 (79) | 12 (92) | 0.3 |
| Remote symptomatic | 1 (7) | 0 (0) | 0.3 |
| Progressive symptomatic | 1 (7) | 1 (7) | 0.9 |
| Potentially fatal etiology, n (%) | 7 (50) | 9 (69) | 0.3 |
| Management data | |||
| ICU stay, d, mean ± sd | 20 (± 20) | 24 (± 38) | 0.9 |
| Number of antiseizure medications, mean ± sd | 2.42 (± 1.16) | 2.54 (± 1.39) | 0.9 |
| SE patients intubated during SE, n (%) | 12 (86) | 9 (69) | 0.3 |
| SE patients with IV anesthetics during SE, n (%) | 11 (79) | 4 (31) | 0.013 |
| Outcome, n (%) | |||
| Death | 3 (21) | 2 (15) | 0.7 |
| Return to premorbid neurologic function | 1 (7) | 6 (46) | 0.021 |
NCSE = nonconvulsive status epilepticus, SE = status epilepticus.
Boldface values indicate statistical significance.